Author

A. A. Adamu

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 2 Scientific Communication & Education· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:benchmarking· 1 Research Focus:drug response / drug discovery· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Y. Bello· 2 shared A. Yunusa· 2 shared C. L. Ochu· 2 shared E. U. Igumbor· 2 shared I. Okoye· 2 shared M. A. Popoola· 2 shared M. B. Bello· 2 shared M. U. Imam· 2 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

A. Y. Bello

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Erythromycin, Retapamulin, Pyridoxine, Folic acid, and Ivermectin dose-dependently inhibit cytopathic effect, Papain-like Protease, and MPRO of SARS-CoV-2

S. O. Bello, M. U. Imam, M. B. Bello, A. Yunusa, A. A. Adamu, A. Shuaibu, E. U. Igumbor, Z. G. Habib, M. A. Popoola, C. L. Ochu, A. Y. Bello, Y. Y. Deeni, I. Okoye

The paper shows that Erythromycin, Retapamulin, Pyridoxine, Folic acid, and Ivermectin inhibit SARS-CoV-2 cytopathic effect and proteases in a dose-dependent manner, with IC50 values within clinical concentrations for most drugs.

bioRxiv · Dec 28, 2022 · PreprintPharmacology & Toxicology

Innovative, rapid, high throughput method for drug repurposing in a pandemic - a case study of SARS-CoV-2 and COVID-19

S. O. Bello, A. Yunusa, A. A. Adamu, M. U. Imam, M. B. Bello, A. B. Shuaibu, E. U. Igumbor, Z. G. Habib, M. A. Popoola, C. L. Ochu, A. Y. Bello, Y. Y. Deeni, I. Okoye

This study identifies potential drugs for COVID-19 by combining computational and wet-lab methods, finding that erythromycin, pyridoxine, folic acid, and retapamulin inhibit SARS-CoV-2 induced cytopathic effect in Vero cells at clinically achievable concentrations.

bioRxiv · Dec 25, 2022Pharmacology & Toxicology

20 years of African Neuroscience: Waking a sleeping giant

M. B. Maina, U. Ahmad, I. A. Harun, H. S. Kwairanga, F. E. Nasr, A. T. Salihu, A. I. Abushouk, A. Muhammad, M. A. Awadelkareem, A. Amin, A. Imam, I. D. Akinrinade, A. H. Yakubu, I. A. Azeez, Y. G. Mohammed, , T. Baden

The paper analyzes 21 years of African neuroscience publications, verifying African leadership and providing metrics to inform policy recommendations for supporting neuroscience research in Africa.

bioRxiv · Jun 3, 2020 · PreprintScientific Communication & Education